| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |